Cite

    P Foley et al.. “Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.” Journal of neurology, neurosurgery and psychiatry, vol. 85, no. 6, 2014, pp. 709–710. http://access.bl.uk/ark:/81055/vdc_100135145910.0x000036